Immediate Management of Active Seizure in the Emergency Department
Administer intravenous lorazepam 4 mg at 2 mg/min immediately—this is the single most important action for any patient actively seizing, with 65% efficacy in terminating seizures and superior performance compared to diazepam. 1
Critical First Steps (0-5 Minutes)
Immediate Benzodiazepine Administration
- Give IV lorazepam 4 mg at 2 mg/min as first-line treatment for the actively seizing patient 1
- Lorazepam demonstrates 59.1% seizure cessation versus 42.6% for diazepam, with longer duration of action 1
- Have airway equipment (bag-valve-mask, intubation supplies) immediately available before administering any benzodiazepine due to respiratory depression risk 1
- If IV access is unavailable, administer IM midazolam 10 mg, which has equivalent efficacy to IV lorazepam 1
Simultaneous Rapid Assessment
- Check fingerstick glucose immediately—hypoglycemia is the most common rapidly reversible cause 1
- Establish continuous oxygen saturation monitoring with supplemental oxygen available 1
- Obtain vital signs and prepare for potential respiratory support 1
If Seizure Continues After 30 Seconds to 5 Minutes
Definition and Escalation Threshold
- Any seizure lasting ≥5 minutes meets the operational definition of status epilepticus and requires immediate escalation to second-line therapy 1
- Do not wait—early treatment prevents benzodiazepine pharmacoresistance that develops within minutes 2
Second-Line Agent Selection (Choose One)
Valproate is the preferred second-line agent based on superior safety profile:
- Administer valproate 30 mg/kg IV (maximum 3000 mg) over 5-20 minutes 1, 3
- Achieves 88% seizure control with 0% hypotension risk 1, 3
- Absolute contraindication in women of childbearing potential due to teratogenicity 1
Alternative second-line options if valproate is contraindicated:
Levetiracetam 30 mg/kg IV (maximum 2500-3000 mg) over 5 minutes 1
Fosphenytoin 20 mg PE/kg IV at maximum rate of 150 PE/min 1
Phenobarbital 20 mg/kg IV over 10 minutes 1
Essential Concurrent Orders
Laboratory Evaluation
- Serum glucose and sodium—the only labs that consistently change acute ED management 1
- Pregnancy test in all patients of childbearing potential 1
- Antiepileptic drug levels if patient has known epilepsy 1
Search for Reversible Causes (Do Not Delay Treatment)
- Hypoglycemia, hyponatremia, hypoxia 1
- Drug toxicity or withdrawal (alcohol, benzodiazepines, barbiturates) 1
- CNS infection, ischemic stroke, intracerebral hemorrhage 1
Neuroimaging Decision
- Emergent non-contrast head CT if any high-risk features present: 1
- Age >40 years
- Recent head trauma
- Focal seizure onset
- Fever or persistent headache
- Anticoagulation use
- Known malignancy or immunocompromised state
- Focal neurologic deficit
- Persistent altered mental status
- CT abnormalities found in 23-41% of first-time seizure presentations 1
- Do not delay anticonvulsant administration to obtain neuroimaging 1
Critical Pitfalls to Avoid
- Never use neuromuscular blockers alone (e.g., rocuronium)—they only mask motor manifestations while allowing continued electrical seizure activity and brain injury 1
- Do not use phenytoin for drug-induced seizures—there is no role for this agent in toxicologic seizures 4
- Do not skip to third-line anesthetic agents (pentobarbital, propofol, midazolam infusion) until benzodiazepines and one second-line agent have been tried 1
- Do not use intramuscular diazepam—absorption is erratic; use rectal route instead if IM administration is being considered 1